U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06813924) titled 'A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants' on Feb. 03.
Brief Summary: The study aims to test if a new medicine called etavopivat potentially affects other medicines in healthy participants. The purpose of the study is to investigate whether the use of etavopivat affects the breakdown and metabolism of commonly used medicines in the body. During the study, participants will receive etavopivat and five different medicines that are already approved and available on the market, and which can be prescribed by doctors. These marketed medicines are called substrate drugs and they are: digoxin, pitav...